Associations of age, immunosuppression, and AIDS among homosexual men in the tricontinental seroconverter study

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 5, 1997, Pages 435-441

  Veugelers, Paul J ^a,b,g   Strathdee, Steffanie A ^b   Kaldor, John M ^c   Page Shafer, Kimberly A ^d   Moss, Andrew R ^e   Schechter, Martin T ^b   Schellekens, Peter Th A ^f   Coutinho, Roel A ^a   Van Griensven, Godfried J P ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CENTRAL LABORATORY   (Netherlands)

^g ST PAUL S HOSPITAL   (Canada)

Author keywords

AIDS and age; CD4+ lymphocytes; Cofactors of disease progression; HIV 1 seroconversion; Kaposi's sarcoma; Opportunistic infections

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AGED; ARTICLE; DISEASE COURSE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; KAPOSI SARCOMA; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEROCONVERSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030985319     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199704150-00007     Document Type: Article

References (38)

1. Moss AR, Bachetti P, Osmond D. Seropositivity for HIV-1 and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988;296:745-50.
2. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989;321:1141-8.
3. Mariotto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol 1992;135:428-37.
4. Kopec-Schrader E, Tindall B, Learmont J. Development of AIDS in people with transfusion-acquired HIV-1 infection. AIDS 1993;135:1009-13.
5. Carré N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C, Rouzioux C. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-1-infected patients: SEROCO Study Group. AIDS 1994;8:797-802.
6. Rosenberg PS, Goedert JJ, Biggar RJ. Effect of age at seroconversion on the natural AIDS incubation distribution: Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters. AIDS 1994;8:803-10.
7. Phillips AN, Sabin CA, Elford J, Bofill M, Janossy G, Lee CA. Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV-1 infection. BMJ 1994; 309:309-13.
8. Polk BF, Fox R, Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;316:61-6.
9. Muñoz A, Vlahov D, Solomon L, et al. Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1992;5:694-700.
10. Keet IPM, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993;7:51-7.
11. Hessol NA, Koblin BA, van Griensven GJP, et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994;139:1077-87.
12. Veugelers PJ, Page KA, Tindall B, et al. Determinants of HIV-1 disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 1994;140:747-58.
13. + T-lymphocyte decline in HIV-1-infected individuals: a Markov modeling approach. J Acquir Immune Defic Syndr 1991;4:1141-7.
14. + T-cell counts. J Acquir Immune Defic Syndr 1991;4:970-5.
15. Lepri AC, Pezzotti P, Dorrucci M, Phillips AN, Rezza G. HIV-1 disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. BMJ 1994;309:1537-42.
16. Mientjes GHC, van Ameijden EJC, van den Hoek JAR, Goudsmit J, Miedema F, Coutinho RA. Progression of HIV-1 infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. AIDS 1993;7:1363-70.
17. Veugelers PJ, Strathdee SA, Tindall B, et al. Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-1-infected homosexual men. AIDS 1994;8:1471-5.
18. Veugelers PJ, Strathdee SA, Moss AR, et al. Is the human immunodeficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the Tricontinental Seroconverter Study. Epidemiology 1995;6:382-6.
19. Lane HC, Masur H, Gelmann EP. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med 1985;78:417-22.
20. Crowe SM, Carlin JB, Stewart KI, Lucas R, Hoy JF. Predictive value of CD4-lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-1-infected persons. J Acquir Immune Defic Syndr 1991;4:770-6.
21. Muñoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. Am J Epidemiol 1993;137:423-38.
22. Broder S, Merigan TC Jr, Bolognesi D. Textbook of AIDS Medicine. Baltimore, Williams & Wilkins, 1994.
23. Rosenberg PS, Biggar RJ, Goedret JJ. Declining age at HIV-1 infection in the United States. N Engl J Med 1994;330:789-90.
24. Schlechter MT, Craib KJP, Le TN, et al. Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. AIDS 1989;3:347-53.
25. Tindall B, Swanson CE, Cooper DA. Development of AIDS in a cohort of HIV-1-seropositive homosexual men in Australia. Med J Aust 1990;153:260-5.
26. van Griensven GJP, Tielman RAP, Goudsmit J, et al. Risk factors and prevalence of HIV-1 antibodies in homosexual men in the Netherlands. Am J Epidemiol 1987;125:1048-57.
27. Winkelstein W, Lyman DM, Padian N, et al. Sexual practices and risk of infection by the human immunodeficiency virus. JAMA 1987;257:321-5.
28. Zeger SL, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
29. Liang K, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
30. Tindall B, Cooper DA. Primary HIV-1 mfection:host responses and intervention strategies. AIDS 1991;5:1-14.
31. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36:1S-15S.
32. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
33. Strathdee SA, Veugelers PJ, Moore PS. The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS 1996;10(Suppl A):551-7.
34. Schwab R, Staiano-Coico L, Weksler ME. Immunological studies of aging. IX. Quantitative differences in T lymphocyte subsets in young and old individuals. Diagn Immunol 1983;1:195-8.
35. Reichert T, DeBruyère M, Deneys V, et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 1991;60:190-208.
36. 2-microglobulin are not adequate to estimate time of HIV-1 infection. AIDS 1994;8:923-33.
37. + lymphocyte endpoints and AIDS in cohorts of homosexual men. AIDS 1993;7:1325-9.
38. + cell count decline during progression to AIDS correlates with HIV-1 phenotype, AIDS 1992;6:665-9.